Key result
T cell-specific Hif-1α ablation accelerates diabetic kidney disease in mice, reducing survival by ~63%.
Why the study?
The role of HIF-1α in diabetic kidney disease and its regulation by high glucose in CD4+ T cells remains controversial and incompletely understood.
A high glucose/ChREBP/Hif-1α transcription axis in CD4+ T cells serves as a self-protection mechanism against diabetic kidney disease progression by limiting the T helper 1 response.
Answers are grounded in this paper and cite their sources.
T cell Hif-1α may protect against diabetic kidney disease progression; hypothesis-generating with no human translation yet.
Diabetic kidney disease (DKD) features intrarenal inflammation, in which T cells play a part. Hypoxia-inducible factor-1α (HIF-1α), a key transcription factor regulating cellular responses to hypoxia, is reportedly involved in the course of inflammation. The role of HIF-1α in DKD has been investigated, but the conclusions are controversial so far. We report a previously unrecognised high glucose/carbohydrate response element binding protein (ChREBP)/Hif-1α transcription axis in CD4+ T cells. Lck-Cre+Hif1aloxp/loxp (Hif-1α−/−) mice were generated to explore the role of T cell HIF-1α in the pathogenesis of DKD. CD4+ T cells sorted from T cell-specific Hif-1α-ablated mice and wild-type mice were used for functional studies and transcriptional profiling. In this study, we used Lck-Cre transgenic mice to specifically disrupt Hif-1α in T cells and found that ablation of Hif-1α greatly accelerated the progression of DKD in a streptozocin-induced model of diabetes. Adoptive transfer of splenic CD4+ T cells from Hif-1α−/− mice rather than wild-type controls to diabetic mice elicited severe renal damage. Compared with wild-type controls, Hif-1α knockout markedly promoted IFN-γ secretion by CD4+ T cells in response to high glucose. Additional Ifn-γ ablation negated the effect of Hif-1α knockout on DKD progression. Mechanistically, the background Hif-1α mRNA synthesis rate in resting T cells was very low, but culture of T cells under high glucose led to significantly promoted Hif-1α expression, which was dependent on the transcription factor ChREBP. Consistent with results from Hif-1α−/− CD4+ T cells, adoptive transfer of Chrebp−/− CD4+ T cells to wild-type diabetic mice also elicited severe diabetic renal damage. By contrast, Chrebp−/−Ifn-γ−/− CD4+ T cells failed to show nephrotoxic effects. Examination of the Hif-1α promoter identified a ChREBP-binding sequence that mediated transcriptional upregulation of Hif-1α by high glucose. Our study reveals a previously unrecognised high glucose/ChREBP/Hif-1α transcription axis in CD4+ T cells, which serves as a self-protection mechanism against DKD progression via limiting T helper 1 response.
No takes yet. Share an insight, caveat, or question.
Zhuang et al. (2025) studied Diabetic kidney disease. T cell-specific Hif-1α ablation vs. Wild-type controls was evaluated on Survival at 12 weeks after STZ injection (p=<0.05). T cell-specific ablation of Hif-1α greatly accelerated the progression of diabetic kidney disease in mice, reducing 12-week survival from 80% to 30% compared to wild-type controls.
Synapse has enriched 10 related papers. Consider them for comparative context: